Literature DB >> 10829996

Vitamin E updated.

J Matthai1.   

Abstract

An improved understanding of its physiology has led to better therapeutic use of vitamin E in recent years. It is a physiological membrane bound antioxidant, protecting cell membrane lipids from oxidant damage by free redicals. Cholestatic liver disease, abetalipoproteinemia and ataxia with vitamin E deficiency are the common deficiency states where vitamin E is of definite therapeutic value, while reports of unproven benefits abound in literature. Vitamin E status of the body can be assessed by serum levels and various functional studies. The new water soluble form, tocopherol polyethylene glycol succinate (TPGS), is therapeutically superior to the standard oral forms available. Details of physiology and therapeutic application of the vitamin are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 10829996     DOI: 10.1007/bf02845251

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  41 in total

1.  ON THE EXISTENCE OF A HITHERTO UNRECOGNIZED DIETARY FACTOR ESSENTIAL FOR REPRODUCTION.

Authors:  H M Evans; K S Bishop
Journal:  Science       Date:  1922-12-08       Impact factor: 47.728

2.  Levels of vitamin E in the plasma of newborn infants and of the mothers.

Authors:  P J Leonard; E Doyle; W Harrington
Journal:  Am J Clin Nutr       Date:  1972-05       Impact factor: 7.045

3.  The effect of vitamin E prophylaxis on the incidence and severity of bronchopulmonary dysplasia.

Authors:  R L Saldanha; E E Cepeda; R L Poland
Journal:  J Pediatr       Date:  1982-07       Impact factor: 4.406

4.  The measurement of nanograms of tocopherol from needle aspiration biopsies of adipose tissue: normal and abetalipoproteinemic subjects.

Authors:  H J Kayden; L J Hatam; M G Traber
Journal:  J Lipid Res       Date:  1983-05       Impact factor: 5.922

5.  Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein.

Authors:  K Ouahchi; M Arita; H Kayden; F Hentati; M Ben Hamida; R Sokol; H Arai; K Inoue; J L Mandel; M Koenig
Journal:  Nat Genet       Date:  1995-02       Impact factor: 38.330

Review 6.  Why don't we use vitamin E in dermatology?

Authors:  K Pehr; R R Forsey
Journal:  CMAJ       Date:  1993-11-01       Impact factor: 8.262

7.  Randomized, double-blind, placebo-controlled, clinical trial of D-alpha-tocopherol (vitamin E) as add-on therapy in uncontrolled epilepsy.

Authors:  G B Raju; M Behari; K Prasad; G K Ahuja
Journal:  Epilepsia       Date:  1994 Mar-Apr       Impact factor: 5.864

8.  The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers.

Authors: 
Journal:  N Engl J Med       Date:  1994-04-14       Impact factor: 91.245

Review 9.  Vitamin E content of foods.

Authors:  P J McLaughlin; J L Weihrauch
Journal:  J Am Diet Assoc       Date:  1979-12

10.  Protection by alpha-tocopherol against skin necrosis induced by doxorubicin hydrochloride.

Authors:  M J Lucero; J Vigo; A M Rabasco; J A Sanchez; F Martin
Journal:  Pharmazie       Date:  1993-10       Impact factor: 1.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.